WHAT'S HOT?

Dennis Quaid Sues the Makers of Heparin Over Twins' Overdose

December 05, 2007 02:51:22 GMT

Dennis Quaid and his wife sued the makers of Heparin, asking for more than $50,000 in damages.


Dennis Quaid
See larger image
Photo credit: Glenn Harris/PR Photos

Dennis Quaid and his wife Kimberly Buffington have on Tuesday December 4th filed a lawsuit against Baxter Healthcare Corp., the makers of the drug Heparin given to their newborn twins, Zoe Grace and Thomas Boone, in an accidental massive overdose last month.

The product liability lawsuit, filed in Chicago, claimed that Baxter Healthcare Corp., based in Deerfield, Ill., was negligent in packaging different doses of the product, on its 10-unit and 10,000-unit, in similar vials with blue backgrounds. The lawsuit furthermore said the company should have recalled the large-dosage vials after overdoses killed three children at an Indianapolis hospital last year.

The Quaids seek at least $50,000 in damages.

The company had not been served with the lawsuit and so could not comment specifically on it, spokeswoman Deborah Spak said. The Quaids' attorney, Susan Loggans, elsewhere insists the case is not about money.

"The objective in this case is not money," Loggans said in a statement. "It's to warn other parents about what happened to them so it won't happen to other families."

The Quaids' newborn twins, Thomas Boone and Zoe Grace, were admitted to the neonatal intensive care unit at Cedars-Sinai Medical Center in Los Angeles on November 18th after they were mistakenly given vials of heparin that were 1,000 times stronger than the usual dosage.

Loggans said "the twins were very critical for a while," but have fully recovered and were recently discharged from the hospital. "The twins are back home," Loggans told People. "Their condition is fantastic, they're smiling. Zoe looks like her mom, and Boone looks like his dad. They've fully recovered from the accident and it's doubtful they'll suffer long-term effects from the overdose."

In related news, Baxter already issued a news release Monday December 3rd outlining the company's new "drug safety initiative" that promises to change the labeling of Heparin vials.

© AceShowbiz.com




Post Your Comments


Screen Name
Please Enter   
Comment
 
 
 
RSS
FB
Twitter